- Report
- January 2026
- 494 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 365 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 471 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 271 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 396 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 566 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 386 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 274 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 384 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 469 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 285 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 284 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 384 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 278 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 465 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 300 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 191 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 380 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 381 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 383 Pages
Global
From €5120EUR$5,850USD£4,437GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more